TITLE

THE USE OF PURE AND IMPURE PLACEBO INTERVENTIONS IN PRIMARY CARE - A QUALITATIVE APPROACH

AUTHOR(S)
Fent, Rahel; Rosemann, Thomas; Fässler, Margrit; Senn, Oliver; Huber, Carola A.
PUB. DATE
June 2011
SOURCE
Romanian Medical Journal;2011, Vol. 58 Issue 2, p141
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Placebos play an important role in clinical trials and several surveys have shown that they are also common in daily practice. Previous research focused primarily on the frequency of placebo use in outpatient care. Our aim was to explore physicians' views on the use of placebos in daily practice, whereby distinction was made between pure placebos (substances with no pharmacological effect, e.g. sugar pills) and impure placebos (substances with pharmacological effect but not on the condition being treated, e.g. antibiotics in viral infections or vitamins). Methods: We performed semi-structured interviews with a sample of twelve primary care physicians (PCPs). The interview addressed individual definitions of a placebo, attitudes towards placebos and the participants' reasons for prescribing them. The interviews were transcribed and analysed using qualitative content analysis. Results: The definition of a placebo given by the majority of the PCPs in our study was one which actually only describes pure placebos. This definition, combined with the fact that most impure placebos were not regarded as placebos at all, means that most of the participating PCPs were not aware of the extent to which placebos are used in daily practice. The PCPs stated that they use placebos (both pure and impure) mainly in the case of non-severe diseases for which there was often no satisfactory somatic explanation. According to the PCPs, cases like this are often treated by complementary and alternative therapies and these, too, are associated with placebo effects. However, all PCPs felt that the ethical aspects of such treatment were unclear and they were unsure as to how to communicate the use of placebos to their patients. Most of them would appreciate ethical guidelines on how to deal with this issue. Conclusions: Many PCPs seem to be unaware that some of the drugs they prescribe are classified as impure placebos. Perceptions of effectiveness and doubts about the legal and ethical aspects of the use of placebos by PCPs may discourage their application. Dissemination of guidelines and consensus papers may be one approach, but it has to be acknowledged that the topic itself is in conflict with the PCPs' perception of themselves as professional and reliable physicians.
ACCESSION #
65162970

 

Related Articles

  • Tricyclics up with SSRIs in meta analysis study. Wynyard, Ruth // New Zealand Doctor;11/2/2005, p8 

    Focuses on the effectiveness of antidepressants in treating depression in the primary care setting according to a research coauthored by Bruce Arroll of Auckland University School of Population Health. Results of the clinical trials of antidepressants; Efficacy of tricyclic antidepressants and...

  • Applying Evidence to Support Ethical Decisions: Is the Placebo Really Powerless? Porzsolt, Franz; Schlotz-Gorton, Nicole; Biller-Andorno, Nikola; Thim, Anke; Meissner, Karin; Roeckl-Wiedmann, Irmgard; Herzberger, Barbara; Ziegler, Renatus; Gaus, Wilhelm; Pöppel, Ernst // Science & Engineering Ethics;Jan2004, Vol. 10 Issue 1, p119 

    Using placebos in day-to-day practice is an ethical problem. This paper summarises the available epidemiological evidence to support this difficult decision. Based on these data we propose to differentiate between placebo and "knowledge framing". While the use of placebo should be confined to...

  • Placebo use in the United Kingdom: results from a national survey of primary care practitioners.  // British Dental Journal;5/11/2013, Vol. 214 Issue 9, p453 

    Ethical implications of using placebos.

  • Placebo Use in the United Kingdom: Results from a National Survey of Primary Care Practitioners. Howick, Jeremy; Bishop, Felicity L.; Heneghan, Carl; Wolstenholme, Jane; Stevens, Sarah; Hobbs, F. D. Richard; Lewith, George // PLoS ONE;Mar2013, Vol. 8 Issue 3, p1 

    Objectives: Surveys in various countries suggest 17% to 80% of doctors prescribe ‘placebos’ in routine practice, but prevalence of placebo use in UK primary care is unknown. Methods: We administered a web-based questionnaire to a representative sample of UK general...

  • Randomised controlled trial of effect of leaflets to empower patients in consultations in primary care. Little, Paul; Dorward, Martina; Stephens, Katharine; Senior, Jane; Kendrick, Tony; Warner, Greg; Moore, Michael // BMJ: British Medical Journal (International Edition);2/21/2004, Vol. 328 Issue 7437, p441 

    Abstract Objective: To assess the impact of leaflets encouraging patients to raise concerns and to discuss symptoms or other health related issues in the consultation. Design: Randomised controlled trial. Setting: Five UK general practices in three settings. Participants: 635 consecutive...

  • ANALYSIS OF ANTIBIOTIC CONSUMPTION FOR TREATING RESPIRATORY TRACT INFECTIONS IN CHILDREN AND COMPLIANCE WITH THE NATIONAL CLINICAL GUIDELINES. LAKIĆ, Dragana; TADIĆ, Ivana; ODALOVIĆ, Marina; TASIĆ, Ljiljana; SABO, Ana; MEĆAVA, Aleksandra // Medicinski Pregled / Medical Review;sep/okt2014, Vol. 67 Issue 9/10, p282 

    Introduction. Respiratory infections are the most common infections in children. The aims of the study were to analyze the use of antibiotics for respiratory infections in the period 2008 -2010 in children's population in region of Niš and to estimate the rational use of antibiotics in...

  • Is C-reactive protein testing useful to predict outcome in patients with acute bronchitis? Llor, Carl; Plana-Ripoll, Oleguer; Moragas, Ana; Bayona, Carolina; Morros, Rosa; Pera, Helena; Miravitlles, Marc // Family Practice;Oct2014, Vol. 31 Issue 5, p530 

    Background. A recent clinical trial could not find differences between anti-inflammatory drugs, antibiotics and placebo in shortening the duration of symptoms in acute bronchitis. Objectives. To investigate if C-reactive protein (CRP) concentrations at presentation are predictive of symptom...

  • Placebos and the UK Medical Research Council--and the consumer perspective. Box, Joan E. // Science & Engineering Ethics;Jan2004, Vol. 10 Issue 1, p95 

    The UK Medical Research Council, in order to further its mission of maintaining and improving human health, supports a substantial number of clinical trials on a wide variety of medical questions; some of these trials involve the use of placebos as controls or to maintain blinding. Before...

  • Use of placebo in clinical trials.  // WHO Drug Information;2001, Vol. 15 Issue 2, p70 

    Discusses the use of placebo in clinical trials, under the revised Declaration of Helsinki. Conditions that govern and restrict the use of placebo in order to avoid unethical use of placebo; Need to respect the patient's right to withdraw at any time, but still receive conventional treatment.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics